Memory Disorders Center Launch Offers Hope for Patients, Families
CINCINNATIPatients and families dealing with memory loss issues will gain an important resource with the official opening of the Memory Disorders Center at the UC Neuroscience Institute on Thursday, May 12, at the UC Health Physicians Office in West Chester.
"Were committed to addressing memory disorders and Alzheimers disease with compassionate care that serves the needs of patients and their families in the Greater Cincinnati area, says Brendan Kelley, MD, the centers director and an associate professor in the University of Cincinnati (UC) Department of Neurology.
Kelleys work is supported by an Endowed Chair in Alzheimers Disease Research and Education, which was established in 2008 with a $1.5 million gift from anonymous donors. That endowment has since grown to over $2 million.
According to the U.S. Centers for Disease Control and Prevention, it is estimated that over 5 million Americans have Alzheimers disease, the most common form of dementia among older adults. In addition, Kelley points out, there are more than 100 conditions associated with cognitive declineincluding trauma, substance abuse, heredity, cardiovascular disease, diabetes, brain tumors and vitamin deficiencies. Many of these conditions are treatable, offering the possibility of substantial improvement in cognitive and behavioral symptoms.
"Through a comprehensive evaluation, the center can differentiate between benign forgetfulness associated with normal aging, mild cognitive impairment and more significant cognitive disturbances such as dementia due to Alzheimers disease, says Kelley.
Kelley, a native of Ohio who trained at Ohio State University, the Cleveland Clinic and the Mayo Clinic, is joined by a second behavioral neurologist, Jennifer Rose Molano, MD. Michael Keys, MD, director of senior adult psychiatry at the Lindner Center of HOPE, is another key team member of the Memory Disorders Center.
Patients will be seen at the UC Health physicians offices in West Chester and Clifton. The centers physicians also have expertise in diagnosing and treating rare cognitive diseases, such as primary progressive aphasia, frontotemporal dementia and autoimmune encephalopathy.
"We take a patient-centered approach that emphasizes the importance of lifestyle modifications and community support in addition to medication management, says Kelley, who adds that the Memory Disorders Center will partner closely with regional organizations such as the Alzheimers Association, the Council on Aging of Southwestern Ohio and the Ohio Geriatrics Society.
The launch, for invited guests, begins with a reception at 6 p.m., followed by a ribbon-cutting ceremony and an optional tour.
The Memory Disorders Center is one of eight specialty centers within the UC Neuroscience Institute (UCNI), a leading treatment, research and teaching center for complex neurological conditions. UCNIs team includes more than 100 faculty members from 14 clinical specialties, with additional centers specializing in brain tumors, cerebrovascular disease and stroke, epilepsy, neurosensory disorders, neurotrauma, Parkinsons disease and movement disorders and multiple sclerosis.
Tags
Related Stories
UC experts say proper produce washing is key defense against Cyclospora
July 17, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
UC students organize free health clinic in community
July 15, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
University of Cincinnati advances FLASH radiation therapy with new clinical trial
July 15, 2026
UC Cancer Center researchers led the FAST-02 trial, showing ultra-high-dose-rate FLASH proton therapy near the heart and lungs safely reduced pain from thoracic bone metastases.